We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lidco Group Plc | LSE:LID | London | Ordinary Share | GB0030546849 | ORD 0.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 11.75 | 11.50 | 12.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
27/6/2017 10:56 | Ha ha BigT20 (8864) lost for words. | willib2 | |
27/6/2017 08:53 | I don't know if any of you have noticed but a sixth MM has joined into the Lidco market, leads to believe the stock is to be more vigorously traded and with an upward movement. | 7767 | |
27/6/2017 08:36 | I wonder if Arf is playing a craft game here ie He is actually adding LID but pretends to be a DEMG bull I know he does charts and TA so he is no mug LID chart and TA beats DEMG by the proverbial mile ... so I think I am right | buywell3 | |
27/6/2017 08:34 | Have had it on good authority from Walbrook that Lidco are starting to make sales and penetrate the Nth American market but wont be making continuous announcements for each contract. | 7767 | |
27/6/2017 08:23 | You would be better off posting buywell's posts over on the doomedtex board. The muppets over there should try doing some research. It is becoming clear which way the wind is blowing. | trentendboy | |
26/6/2017 12:21 | TrentEndBoy (5008) "The Deltex guys must dispair" Perhaps you mean "despair". ...or perhaps you mean "celebrate, jump for joy" "the progress that LID is making - badly managed." I couldn't have put it better myself. | arf dysg | |
26/6/2017 11:22 | buywell3 (5003) "That's as bad as your 100p movement up and down re RSI comment Arf" I suggest you didn't understand what I meant. If the share price goes up a penny on one day, and then it goes down a penny on the next day, and then up a penny the day after, and then down a penny, that's ... count them... FOUR PENCE of total movement. That's "total movement". So... if the total movement over many days is 100p, but the NET movement (last price - first price) is only 1p, that means the RSI is very close to the middle of the scale, i.e. 50. That tells you there's lots of noise but no actual trend. BTW, does Lidco have any actual clinical trials which the Americans would like? | arf dysg | |
26/6/2017 11:20 | The Deltex guys must dispair when they see the progress that LID is making - badly managed. | trentendboy | |
26/6/2017 07:30 | The above was a presentation to institutional investors given after the last results Some interesting stuff in there particularly about the USA The EV/EBITDA for Lidco is $21.23 Million at the current time Which even at today could result in a takeout offer based upon Pulsion takeover in the USA by Maquet of over $200 Million ie 10 X EV/EBITDA 4 X turnover would be a paltry $40 Million or so , average of the two around $120 Million See page 22 in the top Lidco presentation link So my 20p call looks a bit light | buywell3 | |
25/6/2017 18:00 | In my last post , some reading it might doubt my numbers Check this out This shows Lidco in 2020 , 3 years from today are forecast at todays share price , to be on a : FORWARD P/E of 2.86 Yes Two point eight six A half reasonable P/E for a growth stock is 20 Do the maths | buywell3 | |
25/6/2017 17:41 | Buywell, you should post that on the Deltex boardInteresting indeed | trentendboy | |
25/6/2017 17:28 | Worth a read The broker mentioned in the above has 14p on LID Which should be hit once USA sales numbers show they are on the Lidco strategy report targets A buyout premium should make this a potential 20p a share in my opinion If Lidco make inroads into the USA market as per their strategy report,mentioned in a previous post ,then within 3 years they could become a thorn in Edwards side. Last year Lidco was added to the NHS supply chain list, which again will make them a force to be reckoned with by Maquet who are second to Edwards in the USA after acquiring Pulsion for 4 X Turnover , 11 X EBITA EV If Lidco can get the new LiDCOunity v2 into the NHS supply chain then the ante is upped Hemodynamic monitoring LidCo supplies a hemodynamic monitoring system to hospitals which analyses a patient’s blood flow parameters during high-risk surgery and critical illness. There’s a wealth of clinical data demonstrating that this improves mortality. It also helps cut costs by shortening the patient’s stay in hospital. The existing market is estimated at $200 million a year, but this ought to grow as adoption of the technique becomes more widespread. Currently LidCo has a mere 5 per cent share of the global market, with the majority of its revenues coming from the UK where its system is in over half of the country’s hospitals. PICCO (Pulsion) is now owned by Maquet , it came out behind Lidco in a USA test of 4 Hemodynamic products, Lidco's came out number one. So it could be that either Maquet or Edwards buy Lidco as their ; 'disruptive' price offering takes market share. | buywell3 | |
23/6/2017 16:54 | That's as bad as your 100p movement up and down re RSI comment Arf If you want to be taken seriously here , please get with the plot. Thus far you have only been playing this for laughs Losing Money is not funny I would put forward Humour has its place, granted , but I find it always comes off better if the share concerned is going north instead of south, as in the case of DEMG for example. Where I might be a buyer in about 12 months time when they do their second placing ( another imminent I believe as cash in hand must be now around 200K | buywell3 | |
23/6/2017 16:43 | ...or Edwards could be so scared by Lidco's competition that Edwards would sell themselves to Lidco for one dollar. | arf dysg | |
23/6/2017 15:34 | According to Sassone the USA market open to what Lidco sells is $100M Edwards has the biggest share of this If Lidco start making inroads with a better product my take is that Edwards will buy them to protect USA market share | buywell3 | |
23/6/2017 13:22 | 7767, What if the intra-operative technology results in using less time post-operatively, i.e. saves lots of money post-operatively? It sounds as if Edwards haven't considered that. | arf dysg | |
23/6/2017 10:41 | Nice to see some SENSIBLE postings at last. I don't think Edwards will bid because I understand that they are not interested in supplying abroad (I might be wrong?) Also I spoke to the retiring Financial director last year and he said quite categorically that they are not concentrating on the intra operational blood reading as the money is in the post operative care (words to that effect). | 7767 | |
23/6/2017 09:46 | Re my last post I have added Two points here 1. The example given of a cost saving to a hospital of over 300K using the new Lidco software upgrade on LiDCOunity v2 which allows a client to opt for the 'frequent user' pricing model 2. Also note that Sassone himself refers to this as being 'disruptive'; ie this is going to hurt the competition ie in the USA Edwards 3. Also just listen to Sassones' voice towards the end of the interview, the guy is obviously excited as to what is happening, my reading of the interview is that his planned strategy is beginning to work | buywell3 | |
23/6/2017 08:12 | Doomedtex and LoserCo - :-)) | trentendboy | |
23/6/2017 07:56 | This new product LiDCOunity v2 seems to have the potential to gain a decent market share in the USA. Edwards is by far the local USA based market leader , and has been for years now , the second largest USA provider of hemodynamic monitoring is Maquet which got its number 2 slot after buying Pulsion the maker of Picco products. Maquet paid around 4 times turnover or 11 times EV/EBITDA for the acquisition in 2014. Lidco's offerings are regarded by clinical tests to be superior to Picco But clinical evidence has put Lidco ahead of that product and two other competitors That evidence was a few years ago on an older Lidco model (still being sold), but this new model with the same algorithm (IP protected) at its core , but with many new enhanced features could now prove pivotal in gaining increased USA sales together with the much increased number of USA sales staff. Over the next 3 years I expect Lidco to accelerate its USA presence with more USA selected states being targeted for sales by the addition of more sales staff. Plus ROW sales to continue to increase particularly in Asia. Lidco has a major market share within the UK NHS in its area of expertise with around 55%, this new product should help it maintain that lead. However it is in the USA where the company will make the most money now as the new CEO has identified and built his well thought out sales strategy upon. This guy Sassone , is an experienced sales specialist, he is what the company lacked ; now that there is no debt and over £4M cash to allow a long needed and targeted sales drive , primarily into the USA and secondarily into the ROW , turnover and bigger profits should in my opinion follow. The strategy report which starts on page 5 in the link below is one of the most concise and well detailed reports I have ever read in a small cap company , The recent change of chart shape over the last year supports my view, the market likes what it is seeing and hearing from Sassone. He has been incentivised via share options on a sliding scale re increased share price which includes him benefiting if Lidco should be bought out at a higher price within the sliding scale band.see page 19 I think Edwards , added or Maquet ; both in the USA, will buy Lidco within 3 to 5 years. The price at 5 years could be around 50% higher than the price after 3 years. | buywell3 | |
22/6/2017 18:09 | Arf you would know if it was me, Ps I am quite Partial to BigT20s turn of phrase but I do wish he had spelt it correctly so we could soak up his feelings properly | willib2 | |
22/6/2017 15:06 | willib, you'll have to ask GBenson. I don't know any more than you. Maybe the famous soul singer is moonlighting on the Deltex board, but more likely he'd employ someone to do that for him. Who could it be? For all I know, it could be YOU! | arf dysg | |
22/6/2017 13:03 | buywell, how right you are! I didn't want to open the box. I didn't want to lift the LID to see what was inside. | arf dysg | |
22/6/2017 11:19 | Arf, Who is this lightweight GBenson on the Deltex board. | willib2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions